21 CFR Part 250
PART 250—SPECIAL REQUIREMENTS FOR SPECIFIC HUMAN DRUGS
- PART 250—SPECIAL REQUIREMENTS FOR SPECIFIC HUMAN DRUGS
- Chapter I—Food and Drug Administration, Department of Health and Human Services › Subchapter C—Drugs: General
- Subpart A—Drugs Regarded as Misbranded
- § 250.11 Thyroid-containing drug preparations intended for treatment of obesity in humans.
- § 250.12 Stramonium preparations labeled with directions for use in self-medication regarded as misbranded.
- Subpart B—New Drug or Prescription Status of Specific Drugs
- § 250.100 Amyl nitrite inhalant as a prescription drug for human use.
- § 250.101 Amphetamine and methamphetamine inhalers regarded as prescription drugs.
- § 250.102 Drug preparations intended for human use containing certain “coronary vasodilators”.
- §§ 250.103-250.104 [Reserved]
- § 250.105 Gelsemium-containing preparations regarded as prescription drugs.
- §§ 250.106-250.107 [Reserved]
- § 250.108 Potassium permanganate preparations as prescription drugs.
- Subpart C—Requirements for Drugs and Foods
- § 250.201 Preparations for the treatment of pernicious anemia.
- Subpart D—Requirements for Drugs and Cosmetics
- § 250.250 Hexachlorophene, as a component of drug and cosmetic products.
Feedback